Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)

scientific article published on 7 September 2017

Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00103-017-2618-6
P698PubMed publication ID28879392

P2093author name stringGerman Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)
P2860cites workHerpes zoster in Germany: quantifying the burden of diseaseQ21261833
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ27860868
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsQ28254168
Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of LifeQ28315858
Quantification of risk factors for herpes zoster: population based case-control studyQ28657403
Recent advances in varicella-zoster virus infectionQ33664545
Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, GermanyQ33709036
Live vaccine used to prevent the spread of varicella in children in hospitalQ34202755
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyQ34273914
Herpes zoster recurrences more frequent than previously reportedQ34541849
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 yearsQ34635527
Preherpetic neuralgiaQ34801625
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in GermanyQ35000186
Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathyQ35004161
Long-term persistence of zoster vaccine efficacyQ35171857
Comparative biology of latent varicella-zoster virus and herpes simplex virus infectionsQ35229927
Safety and tolerability of zoster vaccine in adults ≥60 years old.Q35881283
Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in GermanyQ35886434
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudyQ35975369
Natural history and treatment of varicella-zoster in high-risk populationsQ36517653
Postherpetic neuralgia: epidemiology, pathophysiology and managementQ36998853
Pathogenesis and current approaches to control of varicella-zoster virus infectionsQ37263293
Herpes Zoster Duplex Unilateralis: Two Cases and Brief Literature ReviewQ37446829
Post-herpetic Neuralgia: a Review.Q38734753
Post-herpetic neuralgia in older patients. Incidence and optimal treatmentQ39479867
Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 YearsQ40891715
Incidence of herpes zoster and its complications in Germany, 2005-2009.Q42186997
Epidemiology and cost of herpes zoster and postherpetic neuralgia in GermanyQ42281395
Disseminated herpes zoster in patients with human immunodeficiency virus infectionQ44341271
Risk factors for postherpetic neuralgia in patients with herpes zosterQ44891234
Seroprevalence of varicella-zoster virus in the German populationQ45735563
Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant motherQ45761229
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster diseaseQ46082829
The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adultsQ48464478
Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in GermanyQ56891583
P433issue10
P921main subjectGermanyQ183
herpes zosterQ182155
attenuated vaccineQ1810913
P304page(s)1162-1179
P577publication date2017-09-07
P1433published inBundesgesundheitsblattQ1006114
P1476titleBackground paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)
P478volume60

Search more.